drugset / Trial / NCT01498874
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether gevokizumab is effective in the treatment of moderate to severe acne vulgaris.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-04
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gevokizumab | Monoclonal antibody | — | Subcutaneous |